Aramark (NYSE:ARMK) received mixed analyst ratings over the past three months, with a recent shift towards a more bullish outlook. The average 12-month price target for Aramark has been raised to $33.5, indicating a 4.69% increase from the previous target. Analysts from firms including Truist Securities, Morgan Stanley, RBC Capital, and Goldman Sachs have adjusted their ratings and price targets, reflecting changes in market conditions and Aramark's performance. Despite positive revenue growth, Aramark faces challenges in profitability, efficiency, and debt management compared to industry benchmarks.